A pair of privately-held developers of editing-based therapies have some successes to show for their recent efforts to ...

Cellares’ Cell Shuttle performed all unit operations in an automated manner, including cell isolation, enrichment, gene ...

To Novartis, fresh late-stage data support the idea that its intrathecal drug, which has the same active ingredient as ...

Bharat Biotech has invested $75 million in its first cell and gene therapy facility in Telangana, India, aiming to launch new ...

The rate of cGVHD-free survival was 78% at 1 year in patients who received Orca-T compared with 38% among patients who ...

REGENXBIO Inc.  today reported new, positive interim data from two additional patients in the Phase I/II portion of the AFFINITY DUCHENNE® trial of RGX-202, a differentiated investigational gene ...

("Teknova”) (Nasdaq: TKNO), and Pluristyx, Inc., today announced that Pluristyx's PluriFreeze™ cryopreservation system is available for purchase exclusively from Teknova. Teknova is a leading producer ...

Increasing Accessibility for Flow Cytometry Applications in Emerging and Established Markets Cytek Muse Micro The Cytek® ...

Using an unbiased approach, this important study discovered a role of Ezh2 in the differentiation of granule neuron precursors, the cell of origin for Shh group of medulloblastoma. Furthermore, the ...

10, 2024 — In a single IV injection, a gene therapy targeting cBIN1 can reverse ... Improved Prime Editing System Makes Gene-Sized Edits in Human Cells at Therapeutic Levels June 10, 2024 ...

The CTA approval is the first regulatory authorisation in Europe to study a non-viral gene-edited TCR-T therapy in clinical practice, paving the way for the execution of Anocca’s scalable clinical ...

The Japan regenerative medicine and cell & gene therapy cold chain logistics market, valued at USD 60.07 million in 2024, is poised for a significant surge, projected to reach USD 209.84 million by ...